Intuitive Surgical, Inc. (NASDAQ:ISRG) is Atika Capital Management LLC’s 6th Largest Position

Atika Capital Management LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 53,600 shares of the medical equipment provider’s stock after selling 600 shares during the period. Intuitive Surgical accounts for about 3.0% of Atika Capital Management LLC’s portfolio, making the stock its 6th biggest position. Atika Capital Management LLC’s holdings in Intuitive Surgical were worth $27,977,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also made changes to their positions in the business. Atala Financial Inc purchased a new position in Intuitive Surgical during the 4th quarter worth $25,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical in the fourth quarter worth about $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Hurley Capital LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Finally, Summit Securities Group LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the transaction, the vice president now owns 473 shares in the company, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 over the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $451.58 on Friday. The business’s 50 day moving average price is $545.18 and its 200-day moving average price is $532.64. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a market capitalization of $160.84 billion, a price-to-earnings ratio of 70.45, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Analyst Ratings Changes

A number of brokerages have issued reports on ISRG. CICC Research started coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Evercore ISI upped their target price on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Wells Fargo & Company upped their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Citigroup raised their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.